Literature DB >> 26392996

A hospital-based tuberculosis focal point to improve tuberculosis care provision in a very high burden setting.

E Jong1, I M Sanne1, A van Rie2, C N Menezes3.   

Abstract

SETTING: A hospital-based tuberculosis focal point (TBFP) at a tertiary hospital in Johannesburg, South Africa.
OBJECTIVE: To describe the possible tasks and impact of a hospital-based TBFP as well as staffing and infrastructure requirements for setting up a hospital-based TBFP. ACTIVITIES: A TBFP can centralize the notification and referral of new TB cases, perform human immunodeficiency virus counseling and testing, assessment of difficult to diagnose TB suspects and management of complicated TB cases, and it can provide an ideal setting for research and health care worker training.
RESULTS: The number of TB suspects assessed by sputum initially increased, followed by a decrease starting in 2010, which correlates with the globally decreasing TB incidence. The proportion of TB cases who failed to link to TB care decreased from 23% to 14% between 2009 and 2012. Almost 40% of cases with hepatotoxicity required an adjusted treatment regimen. Roll-out of Xpert(®) MTB/RIF testing and decentralized drug-resistant TB treatment increased the number of rifampicin monoresistant and sputum smear-negative multidrug-resistant TB cases treated on an out-patient basis.
CONCLUSION: A hospital-based TBFP complements care at primary care level by coordinating TB care for a vulnerable population of patients diagnosed in a hospital setting, and by coordinating the diagnosis and treatment of complex TB cases.

Entities:  

Keywords:  HIV; diagnosis; linkage to care; treatment; tuberculosis

Year:  2013        PMID: 26392996      PMCID: PMC4463085          DOI: 10.5588/pha.12.0073

Source DB:  PubMed          Journal:  Public Health Action        ISSN: 2220-8372


  16 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

2.  Diagnostic yield of tuberculosis using sputum induction in HIV-positive patients before antiretroviral therapy.

Authors:  S D Lawn; A D Kerkhoff; P Pahlana; M Vogt; R Wood
Journal:  Int J Tuberc Lung Dis       Date:  2012-08-03       Impact factor: 2.373

3.  Cohort profile: the Themba Lethu Clinical Cohort, Johannesburg, South Africa.

Authors:  Matthew P Fox; Mhairi Maskew; A Patrick MacPhail; Lawrence Long; Alana T Brennan; Daniel Westreich; William B MacLeod; Pappie Majuba; Ian M Sanne
Journal:  Int J Epidemiol       Date:  2012-03-20       Impact factor: 7.196

4.  Tuberculosis at Chris Hani Baragwanath Hospital: an intervention to improve patient referrals to district clinics.

Authors:  M E Edginton; M L Wong; H J Hodkinson
Journal:  Int J Tuberc Lung Dis       Date:  2006-09       Impact factor: 2.373

5.  Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.

Authors:  N R Gandhi; J R Andrews; J C M Brust; R Montreuil; D Weissman; M Heo; A P Moll; G H Friedland; N S Shah
Journal:  Int J Tuberc Lung Dis       Date:  2012-01       Impact factor: 2.373

6.  Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa.

Authors:  M Loveday; K Wallengren; A Voce; B Margot; T Reddy; I Master; J Brust; K Chaiyachati; N Padayatchi
Journal:  Int J Tuberc Lung Dis       Date:  2012-02       Impact factor: 2.373

7.  Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection.

Authors:  R A M Breen; R F Miller; T Gorsuch; C J Smith; A Schwenk; W Holmes; J Ballinger; L Swaden; M A Johnson; I Cropley; M C I Lipman
Journal:  Thorax       Date:  2006-07-14       Impact factor: 9.139

8.  Factors associated with anti-tuberculosis medication adverse effects: a case-control study in Lima, Peru.

Authors:  Kocfa Chung-Delgado; Alejandro Revilla-Montag; Sonia Guillen-Bravo; Eduardo Velez-Segovia; Andrea Soria-Montoya; Alexandra Nuñez-Garbin; Wilmer Silva-Caso; Antonio Bernabe-Ortiz
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

9.  Trends in drug-resistant tuberculosis in a gold-mining workforce in South Africa, 2002-2008.

Authors:  C L van Halsema; K L Fielding; V N Chihota; J J Lewis; G J Churchyard; A D Grant
Journal:  Int J Tuberc Lung Dis       Date:  2012-05-07       Impact factor: 2.373

10.  Linkage to care and treatment for TB and HIV among people newly diagnosed with TB or HIV-associated TB at a large, inner city South African hospital.

Authors:  Yara Voss De Lima; Denise Evans; Liesl Page-Shipp; Antonia Barnard; Ian Sanne; Colin N Menezes; Annelies Van Rie
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

View more
  4 in total

1.  Lost in time and space: the outcome of patients transferred out from large hospitals.

Authors:  Sven Gudmund Hinderaker; Razia Fatima
Journal:  Public Health Action       Date:  2013-03-21

2.  Closing the reporting gap for childhood tuberculosis in South Africa: improving hospital referrals and linkages.

Authors:  K du Preez; H S Schaaf; R Dunbar; A Swartz; P Naidoo; A C Hesseling
Journal:  Public Health Action       Date:  2020-03-21

3.  Priority Activities in Child and Adolescent Tuberculosis to Close the Policy-Practice Gap in Low- and Middle-Income Countries.

Authors:  Karen du Preez; Betina Mendez Alcântara Gabardo; Sushil K Kabra; Rina Triasih; Trisasi Lestari; Margaret Kal; Bazarragchaa Tsogt; Gantsetseg Dorj; Enkhtsetseg Purev; Thu Anh Nguyen; Lenny Naidoo; Lindiwe Mvusi; Hendrik Simon Schaaf; Anneke C Hesseling; Andrea Maciel de Oliveira Rossoni; Anna Cristina Calçada Carvalho; Claudete Aparecida Araújo Cardoso; Clemax Couto Sant'Anna; Danielle Gomes Dell' Orti; Fernanda Dockhorn Costa; Liliana Romero Vega; Maria de Fátima Pombo Sant'Anna; Nguyen Binh Hoa; Phan Huu Phuc; Attannon Arnauld Fiogbe; Dissou Affolabi; Gisèle Badoum; Abdoul Risgou Ouédraogo; Tandaogo Saouadogo; Adjima Combary; Albert Kuate Kuate; Bisso Ngono Annie Prudence; Aboubakar Sidiki Magassouba; Adama Marie Bangoura; Alphazazi Soumana; Georges Hermana; Hervé Gando; Nafissatou Fall; Barnabé Gning; Mohammed Fall Dogo; Olivia Mbitikon; Manon Deffense; Kevin Zimba; Chishala Chabala; Moorine Penninah Sekadde; Henry Luzze; Stavia Turyahabwe; John Paul Dongo; Constantino Lopes; Milena Dos Santos; Joshua Reginald Francis; Magnolia Arango-Loboguerrero; Carlos M Perez-Velez; Kobto Ghislain Koura; Stephen M Graham
Journal:  Pathogens       Date:  2022-02-01

4.  High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa.

Authors:  Kamban Hirasen; Rebecca Berhanu; Denise Evans; Sydney Rosen; Ian Sanne; Lawrence Long
Journal:  PLoS One       Date:  2018-10-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.